Allison Beck
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Hepatitis C virus research, Mosquito-borne diseases and control, Liver Disease Diagnosis and Treatment, Viral Infections and Outbreaks Research, Viral Infections and Vectors
Most-Cited Works
- → The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial(2017)415 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria(2022)115 cited
- → Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes(2020)105 cited
- → An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults(2023)92 cited
- → Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick(2015)90 cited
- → Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial(2022)86 cited
- → Innate, T-, and B-Cell Responses in Acute Human Zika Patients(2017)78 cited
- → Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial(2022)37 cited
- → Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial(2017)36 cited